Used since 1984 when late Rajiv Gandhi became the PM, the current residence was built over 12 acres of land, based on designs by New Delhi's chief architect Edwin Lutyens. However, with a new redevelopment blueprint on the table, the PM's residence is now expected to move to the South-West corner, behind South Block on Raisina Hill. Arnab Dutta reports.
Reiterating its position, TRAI, which oversees both the telecom and television sectors in the country, said the amendments suggested on January 1 had been done to correct "distortions" in the market and address pricing issues.
At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.
Its proximity to popular tourist destinations like Agra, which attracts 45 per cent of the international passenger traffic at IGI, could be diverted to Jewar.
'If you look at the Number 1 film in India this year across Bollywood and other regional film industries, it is Avengers: Endgame.'
PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.
Chocolate majors in India posted healthy top-line growth in FY19. While Mondelez India Foods - the marketer of Cadbury - continued to lead the pack, Nestle India, which dominates the confectionery space with leading brands like Kitkat and Munch, continues to hold the third spot in revenue. However, two of these companies - Mars International India and Hershey India - still remain in the red.
Concerned about the rise of antibiotic resistance and the time it takes for drugs developed abroad to reach Indians, the government is considering holding its own clinical trials. Clinical trials for new drugs have so far primarily been conducted only by private Indian or foreign drug firms. But given the stringent nature of India's regulatory environment for clinical trials, several pharmaceutical companies have moved their trials out of India. As a result, only 1.2 per cent of global clinical trials take place in India.
According to a senior government official, the plan is to do "collective bargaining" for certain medical devices and implants by assuring a bulk requirement to the manufacturers. "The requirement for these devices runs into millions. We assure them that the requirement is going to be in bulk. In return, they should offer us better rates," he said.
The government said that "in exercise of extraordinary powers in public interest, conferred by paragraph 19 of the DPCO, 2013", the ceiling prices of 21 key formulations had been increased. These formulations include common medicines like BCG vaccines, penicillin, malaria and leprosy medicines (Dapsone), life-saving drugs like Furosemide (used to treat fluid build-up due to heart failure, liver scarring, or kidney disease), vitamin C, some common antibiotics, and anti-allergy medicines.
While Coca-Cola India improved its profit margin during the year, arch rival PepsiCo's margin was far lower. Coca-Cola India, which does not manufacture or market any products, gets majority of its revenue from royalty incomes against ownership of formulations for key products. Over the years, PepsiCo's operating revenue has come down significantly, as it kept divesting bottling plants to its franchise partners.
This means, Coca-Cola group will no longer bottle and market any of its beverages in the country.
The added burden on manufacturers for recycling e-waste is expected to impact their margins, which may further lead them towards hiking prices of other items.
While the company did not reveal its profit or loss for the period, according to its fillings, food and beverages was the largest category - accounting for 62.23 per cent or Rs 5,184 crore of its total sales.
Amid the protests against leading e-commerce firms, Flipkart and Amazon, shipments through the online route in fact witnessed a double-digit growth every quarter.
The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India.
Alleging misconduct by its permanent workers, labour unions and contract staff, the plant management informed all stakeholders, through a notice, that starting Monday "normal operations" at the plant are being suspended.
While Hindware is expecting sale of its air purifiers to double this year, brands like Xiaomi, Blue Star and Daikin, too, are expecting significant rise in sales.
From new and competitively-priced iPhones to slashing prices of its older models, it had a multi-pronged strategy.
Revenue from convenience fees has grown at a compound annual rate of 85 per cent for multiplex chain operator Inox Leisure and 58 per cent for PVR.
